The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- PMID: 20368739
- DOI: 10.1038/nrgastro.2010.41
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide, and is commonly associated with the metabolic syndrome. Secular trends in the prevalence of these diseases may be associated with the increased fructose consumption observed in the Western diet. NAFLD is characterized by two steps of liver injury: intrahepatic lipid accumulation (hepatic steatosis), and inflammatory progression to nonalcoholic steatohepatitis (NASH) (the 'two-hit' theory). In the first 'hit', hepatic metabolism of fructose promotes de novo lipogenesis and intrahepatic lipid, inhibition of mitochondrial beta-oxidation of long-chain fatty acids, triglyceride formation and steatosis, hepatic and skeletal muscle insulin resistance, and hyperglycemia. In the second 'hit', owing to the molecular instability of its five-membered furanose ring, fructose promotes protein fructosylation and formation of reactive oxygen species (ROS), which require quenching by hepatic antioxidants. Many patients with NASH also have micronutrient deficiencies and do not have enough antioxidant capacity to prevent synthesis of ROS, resulting in necroinflammation. We postulate that excessive dietary fructose consumption may underlie the development of NAFLD and the metabolic syndrome. Furthermore, we postulate that NAFLD and alcoholic fatty liver disease share the same pathogenesis.
Similar articles
-
Fructose as a key player in the development of fatty liver disease.World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. World J Gastroenterol. 2013. PMID: 23482247 Free PMC article. Review.
-
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.Dig Dis Sci. 2016 May;61(5):1282-93. doi: 10.1007/s10620-016-4054-0. Epub 2016 Feb 8. Dig Dis Sci. 2016. PMID: 26856717 Free PMC article. Review.
-
Soft drinks consumption and nonalcoholic fatty liver disease.World J Gastroenterol. 2010 Jun 7;16(21):2579-88. doi: 10.3748/wjg.v16.i21.2579. World J Gastroenterol. 2010. PMID: 20518077 Free PMC article.
-
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.J Nutr Biochem. 2012 Mar;23(3):203-8. doi: 10.1016/j.jnutbio.2011.09.006. Epub 2011 Nov 29. J Nutr Biochem. 2012. PMID: 22129639 Review.
-
Fructose consumption as a risk factor for non-alcoholic fatty liver disease.J Hepatol. 2008 Jun;48(6):993-9. doi: 10.1016/j.jhep.2008.02.011. Epub 2008 Mar 10. J Hepatol. 2008. PMID: 18395287 Free PMC article.
Cited by
-
Glucose transporters in the small intestine in health and disease.Pflugers Arch. 2020 Sep;472(9):1207-1248. doi: 10.1007/s00424-020-02439-5. Epub 2020 Aug 23. Pflugers Arch. 2020. PMID: 32829466 Free PMC article. Review.
-
Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.J Nutr. 2013 Mar;143(3):315-23. doi: 10.3945/jn.112.171322. Epub 2013 Jan 9. J Nutr. 2013. PMID: 23303872 Free PMC article.
-
A novel mice model of metabolic syndrome: the high-fat-high-fructose diet-fed ICR mice.Exp Anim. 2015;64(4):435-42. doi: 10.1538/expanim.14-0086. Epub 2015 Jul 2. Exp Anim. 2015. PMID: 26134356 Free PMC article.
-
The Effects of Long-Term High Fat and/or High Sugar Feeding on Sources of Postprandial Hepatic Glycogen and Triglyceride Synthesis in Mice.Nutrients. 2024 Jul 9;16(14):2186. doi: 10.3390/nu16142186. Nutrients. 2024. PMID: 39064628 Free PMC article.
-
ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.J Biol Chem. 2013 Aug 30;288(35):25350-25361. doi: 10.1074/jbc.M113.470526. Epub 2013 Jul 25. J Biol Chem. 2013. PMID: 23888053 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical